Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1510.85 -5.30 (-0.35%) | NSE 1509.90 -7.10 (-0.47%) | Trade | Add

BSE Live

Jan 16, 16:01

1510.85 -5.30 (-0.35%)

Volume

AVERAGE VOLUME

5-Day

28,838

10-Day

23,496

30-Day

14,779

495,166

Prev. Close

1516.15
Open Price

1516.15

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 16, 15:55

1509.90 -7.10 (-0.47%)

Volume

AVERAGE VOLUME

5-Day

429,775

10-Day

351,579

30-Day

253,304

107,415

Prev. Close

1517.00
Open Price

1512.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Ipca Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	4,307.29	3,579.65	3,168.04	3,094.70	2,803.79
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	25.81	56.01	39.40
Revenue From Operations [Net]	4,307.29	3,579.65	3,142.23	3,038.69	2,764.39
Total Operating Revenues	4,367.43	3,633.15	3,193.40	3,102.21	2,803.66
Other Income	64.69	54.59	39.54	20.65	27.67
Total Revenue	4,432.12	3,687.74	3,232.94	3,122.86	2,831.33
EXPENSES
Cost Of Materials Consumed	1,431.10	1,098.02	923.20	947.31	886.01
Purchase Of Stock-In Trade	204.65	167.87	168.30	161.84	138.33
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-155.05	-106.14	20.98	-1.73	22.26
Employee Benefit Expenses	870.79	752.24	712.78	674.93	603.35
Finance Costs	15.79	18.49	24.02	23.34	28.60
Depreciation And Amortisation Expenses	178.69	171.88	174.36	171.00	161.23
Other Expenses	1,101.18	1,027.99	926.50	887.97	880.10
Total Expenses	3,647.15	3,130.35	2,950.14	2,864.66	2,719.88
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	784.97	557.39	282.80	258.20	111.45
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	784.97	557.39	282.80	258.20	111.45
Tax Expenses-Continued Operations
Current Tax	137.98	119.90	60.01	56.95	21.64
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-5.47	-12.40	-9.98	13.00	-2.71
Tax For Earlier Years	0.00	-5.02	-0.34	-0.04	0.00
Total Tax Expenses	132.51	102.48	49.69	69.91	18.93
Profit/Loss After Tax And Before ExtraOrdinary Items	652.46	454.91	233.11	188.29	92.52
Profit/Loss From Continuing Operations	652.46	454.91	233.11	188.29	92.52
Profit/Loss For The Period	652.46	454.91	233.11	188.29	92.52
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	51.64	36.01	18.47	14.92	7.33
Diluted EPS (Rs.)	51.60	36.01	18.47	14.92	7.33
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	257.80
Indigenous Raw Materials	0.00	0.00	0.00	0.00	472.84
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	4.44
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	28.66
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	101.08	12.64	12.62	0.00	12.62
Tax On Dividend	20.77	2.60	2.56	0.00	2.57
Equity Dividend Rate (%)	250.00	150.00	50.00	50.00	0.00